280568-14-1

Basic information

• Product Name: 2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE
• Synonyms: 2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE;N-(2-Isonicotinoylphenyl)pivalaMide
• CAS NO: 280568-14-1
• Molecular Formula: C₁₇H₁₈N₂O₃
• Molecular Weight: 298.34
• Mol File: 280568-14-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE(280568-14-1)
• EPA Substance Registry System: 2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE(280568-14-1)

Safety Data

• Hazardous Substances Data: 280568-14-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE is used as a building block for the synthesis of various pharmaceutical compounds. Its unique molecular structure allows for the creation of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE is used as an intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its potential biological activities make it a valuable component in the development of new agrochemical products.
Used in Medicinal Chemistry Research:
2,2-DIMETHYL-N-[2-(PYRIDINE-4-CARBONYL)-PHENYL]-PROPIONAMIDE is used as a research tool in medicinal chemistry. Its properties and structure enable scientists to study its interactions with biological targets, potentially leading to the discovery of new drugs and therapeutic agents.

Upstream product

• 280568-13-0 C₁₇H₂₀N₂O₃ 

Downstream Products

• 91973-39-6 (2-Aminophenyl)-(pyridin-4-yl)methanone 

Relevant articles and documents

Succinoylaminobenzodiazepines as inhibitors of Abeta protein production

This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome.